Showing results (471-480 of 494) with videos related to
Sort By:
Pageof 50
Proceedings of the National Academy of Sciences of the United States of America|October 27, 1999
A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2V S Goldmacher, L M Bartle, A Skaletskaya, et al.Neuro-Oncology|February 5, 2011
Hot spots in dynamic (18)FET-PET delineate malignant tumor parts within suspected WHO grade II gliomasM Kunz, N Thon, S Eigenbrod, et al.Bioconjugate Chemistry|March 24, 2011
Disulfide-linked antibody-maytansinoid conjugates: optimization of in vivo activity by varying the steric hindrance at carbon atoms adjacent to the disulfide linkageBrenda A Kellogg, Lisa Garrett, Yelena Kovtun, et al.Journal of Strength and Conditioning Research|February 6, 2024
Sex Does Not Affect Changes in Body Composition and Insulin-Like Growth Factor-I During US Army Basic Combat TrainingBrandon M Roberts, Jeffery S Staab, Aaron R Caldwell, et al.Xenotransplantation|February 7, 2013
Double knockout pigs deficient in N-glycolylneuraminic acid and galactose α-1,3-galactose reduce the humoral barrier to xenotransplantationAndrew J Lutz, Ping Li, Jose L Estrada, et al.Journal of Medicinal Chemistry|July 11, 2006
Semisynthetic maytansine analogues for the targeted treatment of cancerWayne C Widdison, Sharon D Wilhelm, Emily E Cavanagh, et al.Stroke|August 24, 2017
Unexplained Variation for Hospitals' Use of Inpatient Rehabilitation and Skilled Nursing Facilities After an Acute Ischemic StrokeYing Xian, Laine Thomas, Li Liang, et al.Stroke|January 25, 2014
Risk adjustment of ischemic stroke outcomes for comparing hospital performance: a statement for healthcare professionals from the American Heart Association/American Stroke AssociationIrene L Katzan, John Spertus, Janet Prvu Bettger, et al.Cancer Research|May 1, 2002
Prostate stem cell antigen as therapy target: tissue expression and in vivo efficacy of an immunoconjugateSarajane Ross, Susan D Spencer, Ilona Holcomb, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2009
The monoclonal antibody nBT062 conjugated to cytotoxic Maytansinoids has selective cytotoxicity against CD138-positive multiple myeloma cells in vitro and in vivoHiroshi Ikeda, Teru Hideshima, Mariateresa Fulciniti, et al.Pageof 50